Literature DB >> 7686366

Regulation of ligand binding to glycoprotein IIb-IIIa (integrin alpha IIb beta 3) in isolated platelet membranes.

S S Smyth1, L V Parise.   

Abstract

The major platelet integrin, glycoprotein IIb-IIIa, binds soluble fibrinogen only after platelet activation. To investigate the mechanism by which platelets convert glycoprotein IIb-IIIa into a functional fibrinogen receptor, we characterized the opening and closing of fibrinogen-binding sites in isolated platelet membranes and compared the regulatory properties of membrane-bound glycoprotein IIb-IIIa with those of the detergent-solubilized receptor. Basal fibrinogen binding to the membranes possessed many of the properties of fibrinogen binding to activated platelets; however, less than 10% of glycoprotein IIb-IIIa in the membranes was capable of binding fibrinogen. Preincubating the membranes with either an activating glycoprotein IIb-IIIa antibody or alpha-chymotrypsin increased fibrinogen binding. In contrast, agents that require intracellular mediators, such as platelet agonists, guanine-nucleotide-binding-protein activators and purified protein kinase C, did not stimulate fibrinogen binding to the membranes, suggesting that cytosolic factor(s) may be required for activation of the receptor in platelets. Occupancy of glycoprotein IIb-IIIa in the membranes with RGD (Arg-Gly-Asp)-containing peptides reversibly exposed neoantigenic epitopes and fibrinogen-binding sites in the receptor. These conformational changes required membrane fixation to be maintained following peptide removal. Similar results were obtained with purified glycoprotein IIb-IIIa incorporated into phospholipid vesicles, indicating that the resting state of the receptor is favoured in these environments. In contrast, when the conformation of detergent-solubilized glycoprotein IIb-IIIa was altered by exposure to RGD-containing peptides, the receptor remained active even after incorporation into phospholipid vesicles. These results demonstrate that platelet membranes are a useful model in which to study the regulation of glycoprotein IIb-IIIa and suggest that the environment surrounding the receptor may have a profound influence on this process.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686366      PMCID: PMC1134177          DOI: 10.1042/bj2920749

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  50 in total

1.  Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9.

Authors:  S J Shattil; M Cunningham; T Wiedmer; J Zhao; P J Sims; L F Brass
Journal:  J Biol Chem       Date:  1992-09-15       Impact factor: 5.157

2.  Reversible conformational changes induced in glycoprotein IIb-IIIa by a potent and selective peptidomimetic inhibitor.

Authors:  W C Kouns; D Kirchhofer; P Hadváry; A Edenhofer; T Weller; G Pfenninger; H R Baumgartner; L K Jennings; B Steiner
Journal:  Blood       Date:  1992-11-15       Impact factor: 22.113

3.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

4.  Protein kinase C and cyclic AMP regulate reversible exposure of binding sites for fibrinogen on the glycoprotein IIB-IIIA complex of human platelets.

Authors:  G van Willigen; J W Akkerman
Journal:  Biochem J       Date:  1991-01-01       Impact factor: 3.857

5.  Monoclonal antibodies to ligand-occupied conformers of integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) alter receptor affinity, specificity, and function.

Authors:  A L Frelinger; X P Du; E F Plow; M H Ginsberg
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.157

6.  Activation of the fibrinogen receptor on human platelets exposed to alpha chymotrypsin. Relationship with a major proteolytic cleavage at the carboxyterminus of the membrane glycoprotein IIb heavy chain.

Authors:  D Pidard; A L Frelinger; C Bouillot; A T Nurden
Journal:  Eur J Biochem       Date:  1991-09-01

7.  Ligands "activate" integrin alpha IIb beta 3 (platelet GPIIb-IIIa).

Authors:  X P Du; E F Plow; A L Frelinger; T E O'Toole; J C Loftus; M H Ginsberg
Journal:  Cell       Date:  1991-05-03       Impact factor: 41.582

8.  Phosphorylation of human platelet glycoprotein IIIa (GPIIIa). Dissociation from fibrinogen receptor activation and phosphorylation of GPIIIa in vitro.

Authors:  C A Hillery; S S Smyth; L V Parise
Journal:  J Biol Chem       Date:  1991-08-05       Impact factor: 5.157

9.  Modulation of the affinity of integrin alpha IIb beta 3 (GPIIb-IIIa) by the cytoplasmic domain of alpha IIb.

Authors:  T E O'Toole; D Mandelman; J Forsyth; S J Shattil; E F Plow; M H Ginsberg
Journal:  Science       Date:  1991-11-08       Impact factor: 47.728

10.  Ser-752-->Pro mutation in the cytoplasmic domain of integrin beta 3 subunit and defective activation of platelet integrin alpha IIb beta 3 (glycoprotein IIb-IIIa) in a variant of Glanzmann thrombasthenia.

Authors:  Y P Chen; I Djaffar; D Pidard; B Steiner; A M Cieutat; J P Caen; J P Rosa
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

View more
  6 in total

1.  Tetrafibricin, a novel non-peptide fibrinogen receptor antagonist, induces conformational changes in glycoprotein IIb/IIIa.

Authors:  T Satoh; W C Kouns; Y Yamashita; T Kamiyama; B Steiner
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

2.  Controlling Surface-Induced Platelet Activation by Agarose and Gelatin-Based Hydrogel Films.

Authors:  Gurunath Apte; Annerose Lindenbauer; Jörg Schemberg; Holger Rothe; Thi-Huong Nguyen
Journal:  ACS Omega       Date:  2021-04-13

3.  Integrin cytoplasmic domains mediate inside-out signal transduction.

Authors:  T E O'Toole; Y Katagiri; R J Faull; K Peter; R Tamura; V Quaranta; J C Loftus; S J Shattil; M H Ginsberg
Journal:  J Cell Biol       Date:  1994-03       Impact factor: 10.539

4.  Novel Role for the AnxA1-Fpr2/ALX Signaling Axis as a Key Regulator of Platelet Function to Promote Resolution of Inflammation.

Authors:  Elena Y Senchenkova; Junaid Ansari; Felix Becker; Shantel A Vital; Zaki Al-Yafeai; Erica M Sparkenbaugh; Rafal Pawlinski; Karen Y Stokes; Jennifer L Carroll; Ana-Maria Dragoi; Cheng Xue Qin; Rebecca H Ritchie; Hai Sun; Hugo H Cuellar-Saenz; Mara R Rubinstein; Yiping W Han; A Wayne Orr; Mauro Perretti; D Neil Granger; Felicity N E Gavins
Journal:  Circulation       Date:  2019-06-03       Impact factor: 29.690

5.  A Multiscale Model for Recruitment Aggregation of Platelets by Correlating with In Vitro Results.

Authors:  Prachi Gupta; Peng Zhang; Jawaad Sheriff; Danny Bluestein; Yuefan Deng
Journal:  Cell Mol Bioeng       Date:  2019-07-09       Impact factor: 2.321

6.  Rupture Forces among Human Blood Platelets at different Degrees of Activation.

Authors:  Thi-Huong Nguyen; Raghavendra Palankar; Van-Chien Bui; Nikolay Medvedev; Andreas Greinacher; Mihaela Delcea
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.